Patent · US Active

Cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases

US9376380B2 · kind B2 · utility

2Cited by
5References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 2014
Grant dateJun 28, 2016
Priority date—
Expiry dateJun 16, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2603/74
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Cannabionid receptor-2 inverse antagonists include compounds represented by Formula IV, or a pharmaceutically acceptable salt thereof:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.